...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Critical roles for IFN-β in lymphoid development, myelopoiesis, and tumor development: Links to tumor necrosis factor α
【24h】

Critical roles for IFN-β in lymphoid development, myelopoiesis, and tumor development: Links to tumor necrosis factor α

机译:IFN-β在淋巴发育,骨髓生成和肿瘤发展中的关键作用:与肿瘤坏死因子α的联系

获取原文
获取原文并翻译 | 示例
           

摘要

We have generated mice null for IFN-β and report the diverse consequences of IFN-β for both the innate and adaptive arms of immunity. Despite no abnormalities in the proportional balance of CD4 and CD8 T cell populations in the peripheral blood, thymus, and spleen of IFN-β~(-/-) mice, activated lymph node and splenic T lymphocytes exhibit enhanced T cell proliferation and decreased tumor necrosis factor a production, relative to IFN-β~(+/+) mice. Notably, constitutive and induced expression of tumor necrosis factor a is reduced in the spleen and bone marrow (BM) macro-phages, respectively, of IFN-β~(-/-) mice. We also observe an altered splenic architecture in IFN-β~(-/-) mice and a reduction in resident macrophages. We identify a potential defect in B cell maturation in IFN-β~(-/-) mice, associated with a decrease in B220~(+ve/high)/CD43~(-ve) BM-derived cells and a reduction in BP-1, IgM, and CD23 expression. Circulating IgM-, Mac-1-, and Gr-1-positive cells are also substantially decreased in IFN-β~(-/-) mice. The decrease in the numbers of circulating macrophages and granulocytes likely reflects defective maturation of primitive BM hematopoiesis in mice, shown by the reduction of colony-forming units, granulocyte-macrophage. We proceeded to evaluate the in vivo growth of malignant cells in the IFN-β~(-/-) background and give evidence that Lewis lung carcinoma-specific tumor growth is more aggressive in IFN-β~(-/-) mice. Taken altogether, our data suggest that, in addition to the direct growth-inhibitory effects on tumor cells, IFN-β is required during different stages of maturation in the development of the immune system.
机译:我们已经产生了对IFN-β无效的小鼠,并报告了IFN-β对免疫的先天性和适应性的不同影响。尽管IFN-β〜(-/-)小鼠外周血,胸腺和脾脏中CD4和CD8 T细胞群的比例平衡没有异常,但活化的淋巴结和脾T淋巴细胞显示出增强的T细胞增殖和肿瘤减少相对于IFN-β〜(+ / +)小鼠,坏死因子a的产生。值得注意的是,在TNF-α-(-/-)小鼠的脾脏和骨髓(BM)巨噬细胞中,肿瘤坏死因子α的组成型和诱导表达分别降低。我们还观察到在IFN-β〜(-/-)小鼠中脾脏结构的改变和驻留巨噬细胞的减少。我们发现在IFN-β〜(-/-)小鼠中B细胞成熟的潜在缺陷,与B220〜(+ ve / high)/ CD43〜(-ve)BM来源的细胞减少和BP减少有关-1,IgM和CD23表达。在IFN-β〜(-/-)小鼠中,循环中的IgM-,Mac-1和Gr-1阳性细胞也大大减少。循环巨噬细胞和粒细胞数量的减少可能反映了小鼠原始BM造血功能的成熟缺陷,表现为集落形成单位粒细胞巨噬细胞减少。我们着手评估在IFN-β〜(-/-)背景下恶性细胞的体内生长,并提供证据表明Lewis肺癌特异性肿瘤在IFN-β〜(-/-)小鼠中更具侵略性。总而言之,我们的数据表明,除了对肿瘤细胞的直接生长抑制作用外,在免疫系统发育的不同成熟阶段还需要IFN-β。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号